Metraipolis › archive › dc_714c4ef83020

PrPC-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced… — Europe PMC PMID:41683587

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41683587
DOI
10.3390/ijms27031159
License (as archived)
solo-consultazione
Archived
2026-11-06T13:08:18.973Z
SHA-256 of the archived text
e98ee1e4fe0356e890c4110bfbb5242fa27751c49a4f7a93191785d2707fea1d
Stable URL of this page
https://metraipolis.com/documento/dc_714c4ef83020

How to cite

PrPC-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced… — Europe PMC PMID:41683587 — Europe PMC (en), https://europepmc.org/article/MED/41683587 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_714c4ef83020 (Metraipolis archive dc_714c4ef83020, sha256 e98ee1e4fe0356e890c4110bfbb5242fa27751c49a4f7a93191785d2707fea1d)
BibTeX
@misc{dc714c4ef83020,
  title = {PrPC-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced… — Europe PMC PMID:41683587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41683587},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_714c4ef83020; sha256 e98ee1e4fe0356e890c4110bfbb5242fa27751c49a4f7a93191785d2707fea1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41683587. Agents can read the archived copy with the MCP tool read_document.